UNH
Income statement / Annual
Last year (2024), UnitedHealth Group Incorporated's total revenue was $400.28 B,
an increase of 8.91% from the previous year.
In 2024, UnitedHealth Group Incorporated's net income was $14.41 B.
See UnitedHealth Group Incorporated,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$400.28 B |
$367.53 B |
$322.13 B |
$285.27 B |
$255.64 B |
$242.16 B |
$226.25 B |
$201.16 B |
$184.83 B |
$157.11 B |
| Cost of Revenue |
$310.88 B
|
$280.66 B
|
$244.55 B
|
$217.95 B
|
$190.14 B
|
$184.56 B
|
$172.40 B
|
$154.15 B
|
$141.45 B
|
$120.08 B
|
| Gross Profit |
$89.40 B
|
$86.87 B
|
$77.59 B
|
$67.33 B
|
$65.50 B
|
$57.60 B
|
$53.85 B
|
$47.01 B
|
$43.37 B
|
$37.03 B
|
| Gross Profit Ratio |
0.22
|
0.24
|
0.24
|
0.24
|
0.26
|
0.24
|
0.24
|
0.23
|
0.23
|
0.24
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$57.11 B
|
$54.63 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Other Expenses |
$0.00
|
-$117.00 M
|
$3.40 B
|
$3.10 B
|
$2.89 B
|
$2.72 B
|
$2.43 B
|
$2.25 B
|
$1.69 B
|
$1.69 B
|
| Operating Expenses |
$57.11 B
|
$54.51 B
|
$51.18 B
|
$45.68 B
|
$44.60 B
|
$37.91 B
|
$36.50 B
|
$31.80 B
|
$30.09 B
|
$26.01 B
|
| Cost And Expenses |
$367.99 B
|
$339.26 B
|
$295.73 B
|
$263.63 B
|
$234.74 B
|
$222.47 B
|
$208.90 B
|
$185.95 B
|
$171.55 B
|
$146.09 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
-$3.91 B
|
$3.25 B
|
$2.09 B
|
$1.66 B
|
$1.66 B
|
$1.70 B
|
$1.40 B
|
$1.19 B
|
$1.07 B
|
$790.00 M
|
| Depreciation & Amortization |
$4.10 B
|
$3.97 B
|
$3.40 B
|
$3.10 B
|
$2.89 B
|
$2.72 B
|
$2.43 B
|
$2.25 B
|
$2.06 B
|
$1.69 B
|
| EBITDA |
$9.77 B |
$32.52 B |
$31.84 B |
$27.07 B |
$25.30 B |
$22.41 B |
$19.77 B |
$17.45 B |
$14.99 B |
$12.71 B |
| EBITDA Ratio |
0.02
|
0.09
|
0.09
|
0.09
|
0.09
|
0.09
|
0.09
|
0.09
|
0.08
|
0.08
|
| Operating Income Ratio |
0.08
|
0.09
|
0.09
|
0.08
|
0.09
|
0.08
|
0.08
|
0.08
|
0.07
|
0.07
|
| Total Other Income/Expenses Net |
-$12.22 B
|
-$3.25 B
|
-$2.09 B
|
-$1.66 B
|
-$1.66 B
|
-$1.70 B
|
-$1.40 B
|
-$1.19 B
|
-$1.07 B
|
-$790.00 M
|
| Income Before Tax |
$20.07 B
|
$29.11 B
|
$26.34 B
|
$22.31 B
|
$20.74 B
|
$17.98 B
|
$15.94 B
|
$14.02 B
|
$12.21 B
|
$10.23 B
|
| Income Before Tax Ratio |
0.05
|
0.08
|
0.08
|
0.08
|
0.08
|
0.07
|
0.07
|
0.07
|
0.07
|
0.07
|
| Income Tax Expense |
$4.83 B
|
$5.97 B
|
$5.70 B
|
$4.58 B
|
$4.97 B
|
$3.74 B
|
$3.56 B
|
$3.20 B
|
$4.92 B
|
$4.36 B
|
| Net Income |
$14.41 B
|
$22.38 B
|
$20.12 B
|
$17.29 B
|
$15.40 B
|
$13.84 B
|
$11.99 B
|
$10.56 B
|
$7.24 B
|
$5.81 B
|
| Net Income Ratio |
0.04
|
0.06
|
0.06
|
0.06
|
0.06
|
0.06
|
0.05
|
0.05
|
0.04
|
0.04
|
| EPS |
15.51 |
24.12 |
21.54 |
18.33 |
16.28 |
14.55 |
12.45 |
10.95 |
7.37 |
6.1 |
| EPS Diluted |
15.51 |
23.86 |
21.18 |
18.08 |
16.03 |
14.33 |
12.19 |
10.72 |
7.25 |
6.01 |
| Weighted Average Shares Out |
$929.00 M
|
$928.00 M
|
$934.00 M
|
$943.00 M
|
$946.00 M
|
$951.00 M
|
$963.00 M
|
$964.00 M
|
$952.00 M
|
$953.00 M
|
| Weighted Average Shares Out Diluted |
$929.00 M
|
$938.00 M
|
$950.00 M
|
$956.00 M
|
$961.00 M
|
$966.00 M
|
$983.00 M
|
$985.00 M
|
$968.00 M
|
$967.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
